& Russell, R
You are down 17% of your starting body weight, and the trajectory has not even begun to flatten
Tirzepatide is a dual GIP and GLP-1 receptor agonist , meaning it mimics two important gut hormones involved in metabolic regulation: After you eat, these hormones: Tirzepatide activates these receptors in the pancreas, gut, brain, and fatty tissues, leading to significant improvements in blood sugar control and weight loss
Slower weight reduction may allow your skin and tissues more time to adapt
Semaglutide for weight management is typically administered as a once-weekly subcutaneous injection, given in the abdomen, thigh, or upper arm
Funding Open access funding provided by HEAL-Link Greece